TRexBio Alternatives & Competitors
12 companies similar to TRexBio — Decoding Human Tissue Biology to Create Revolutionary Therapeutics
Companies similar to TRexBio
Enlaza Therapeutics
Pioneering Covalent Biologics
Granza Bio
Reprogramming Immunity for Target-Specific Medicines
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Rival Readout
Competing with TRexBio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Interius BioTherapeutics
Interius is developing new ways to engineer cells inside the human body, right where they...
Autolus Therapeutics
Focused on the development of precisely targeted, controlled & highly active T cell therap...
Sudo Biosciences
Developing precision TYK2 therapeutics.
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
Adendra Therapeutics
Translating dendritic cell biology into new therapies for cancer and autoimmunity.
AusperBio
Transforming Patient Lives For a Better Tomorrow
BlueRock Therapeutics
Striving to transform the treatment of disease by harnessing the power of cell therapy
About TRexBio
TRexBio is a clinical-stage biotechnology company that is focused on developing immunoregulatory medicines. Founded in 2018 and headquartered in South San Francisco, California, the company is pioneering advances in tissue Treg biology to combat inflammatory diseases. Their commitment to decoding human tissue biology i...
Development of biologics targeting immune balance, Decoding regulatory T cell behavior in human tissue, Creation of tissue-specific therapeutics
Patients with autoimmune diseases, Patients with inflammatory conditions, Healthcare providers in dermatology and gastroenterology
Clinical-stage, Immunoregulatory Medicines, Tissue Biology, Computational Biology, Human Tissue Focus, Immunobiology Expertise, Treg Behavior Mapping, Novel Targets Identification, Therapeutic Intervention, TNFR2-selective Agonist, Effector Tregs Activation, Inflammatory Diseases, Atopic Dermatitis, Immune Homeostasis Restoration
B2B, B2D
Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around TRexBio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at TRexBio on 9 Jun 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.